| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1368725 | Bioorganic & Medicinal Chemistry Letters | 2016 | 4 Pages |
Abstract
The synthesis and the biological evaluation of a new ferrocenyl-iminosugar conjugate designed for fucosidase inhibitory and anticancer activity is described. The compound showed strong affinity for fucosidase from bovine kidney (Ki = 23 nM) and from Bacteroides thetaiotaomicron (Ki = 150 nM), displaying a 10-fold tighter binding affinity for these enzymes than the previous analogs. The interaction pattern that improves binding has been evaluated through structural analysis of the inhibitor–enzyme complex. The ferrocenyl-iminosugar exhibits significant anticancer activity on MDA-MB-231 and SK-MEL28 cell lines at 100 μM.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Audrey Hottin, Amandine Scandolera, Laurent Duca, Daniel W. Wright, Gideon J. Davies, Jean-Bernard Behr,